These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26352904)

  • 41. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol.
    Yoong W; Ridout AE; Damodaram M; Dadswell R
    BJU Int; 2010 Dec; 106(11):1673-6. PubMed ID: 20590544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson's disease: A randomized clinical trial.
    Araujo TG; Schmidt AP; Sanches PRS; Silva Junior DP; Rieder CRM; Ramos JGL
    Neurourol Urodyn; 2021 Jan; 40(1):538-548. PubMed ID: 33326648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients.
    Te Dorsthorst MJ; Heesakkers JPFA; van Balken MR
    Neurourol Urodyn; 2020 Feb; 39(2):702-706. PubMed ID: 31845404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease.
    Kabay SC; Kabay S; Yucel M; Ozden H
    Neurourol Urodyn; 2009; 28(1):62-7. PubMed ID: 18837432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months.
    Vecchioli-Scaldazza C; Morosetti C
    Int Braz J Urol; 2018; 44(1):102-108. PubMed ID: 29064651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
    Kapur A; Aalami Harandi A; Hartman-Kenzler J; Kim J
    Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of idiopathic overactive bladder in women: Transcutaneous tibial nerve stimulation alone versus combined with pelvic floor muscle training].
    Baati R; Balhi S; Saadi A; Kraiem R; Kennou B; Ayed H; Chebil M
    Prog Urol; 2020 Dec; 30(17):1126-1133. PubMed ID: 32682849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
    Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of percutaneous tibial nerve stimulation (PTNS) for fecal incontinence: a prospective cohort study.
    Hotouras A; Murphy J; Walsh U; Allison M; Curry A; Williams NS; Knowles C; Chan CL
    Ann Surg; 2014 May; 259(5):939-43. PubMed ID: 23979291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.
    Boudaoud N; Binet A; Line A; Chaouadi D; Jolly C; Fiquet CF; Ripert T; Merol ML
    J Pediatr Urol; 2015 Jun; 11(3):138.e1-10. PubMed ID: 25979217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study.
    Zecca C; Digesu GA; Robshaw P; Singh A; Elneil S; Gobbi C
    J Urol; 2014 Mar; 191(3):697-702. PubMed ID: 24076308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
    Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
    Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement in overactive bladder symptoms in patients using functional electrical stimulation of the common peroneal nerve for walking.
    Hare N; Georgopoulos P; Philips KE; Johnson JE; Seary C; Panicker JN; Stevenson VL
    Clin Rehabil; 2018 Oct; 32(10):1357-1362. PubMed ID: 29909652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population.
    Zinkgraf K; Quinn AO; Ketterhagen D; Kreuziger B; Stevenson K
    Urol Nurs; 2009; 29(1):30-4. PubMed ID: 19331273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravesical electrical stimulation treatment for overactive bladder: An observational study.
    Yune JJ; Shen JK; Pierce MA; Hardesty JS; Kim J; Siddighi S
    Investig Clin Urol; 2018 Jul; 59(4):246-251. PubMed ID: 29984339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder.
    Liao L; Li X; Chong T; Chen Q; Xu Z; Huang B; Chen M; Li H; Wei Z; Shao Y; Lu J; Pang R; Li X; Wang Y
    BJU Int; 2024 Jun; 133(6):760-769. PubMed ID: 38468422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.